SCHEMBL4947405

SCHEMBL4947405

CC(N)c1ccc(-c2cccnc2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 14/20 0.57
CYP2C19 P33261 8/20 0.57
CYP2C9 P11712 8/20 0.57
CYP3A4 P08684 8/20 0.57
CYP2E1 P05181 7/20 0.57
CYP2D6 P10635 6/20 0.57
CYP2B6 P20813 6/20 0.57
MKNK1 Q9BUB5 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
WRN Q14191 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10022413 0.86 CYP2A6 (0.56) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL16088989 0.80 ALOX5 (0.55) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL30766000 0.80 ALOX5 (0.55) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL506674 0.80 ALOX5 (0.55) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL13073681 0.80 CYP2A6 (0.50) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
Hydrochloric Acid SCHEMBL30765894 0.79 ALOX5 (0.54) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL29854440 0.78 CYP2A6 (0.73) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL16088995 0.78 HPGDS (0.51) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL434197 0.74 CYP2A6 (0.63) CYP2A6CYP2C19CYP2C9CYP3A4CYP2E1
SCHEMBL706693 0.73 ALOX5 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer CYP2A13, CYP2A6, CYP2B6 CYP2A6 2/4885CYP2C19 41/4885CYP2C9 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.